ADC Therapeutics
Duygu Yazar Toyran is an experienced professional in pharmacovigilance and regulatory affairs, currently serving as the Director of Pharmacovigilance Quality at ADC Therapeutics since August 2021. Prior roles include Associate Director of Pharmacovigilance Systems and Operations at ADC Therapeutics and various positions at Novartis from January 2015 to July 2021, including Country Patient Safety Head and Senior Patient Safety Specialist. Duygu also worked as an International Markets Technical Regulatory Affairs Specialist at DEVA Holding A.Ş. from August 2013 to December 2014. Academic qualifications include a Master of Science in Pharmacology from King's College London and a Bachelor of Science in Pharmacy from Istanbul University, along with additional education in Business Administration from the London School of Economics.
This person is not in any teams
This person is not in any offices
ADC Therapeutics
2 followers
ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.